Clinical Trials List
2007-07-01 - 2019-10-24
Phase III
Terminated4
ICD-10C92.10
Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
ICD-10C92.12
Chronic myeloid leukemia, BCR/ABL-positive, in relapse
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9205.10
Chronic myeloid leukemia, without mention of remission
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- 徐思淳 無
- Jih-Luh Tang 無
The Actual Total Number of Participants Enrolled
0 Stop recruiting
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
771 participants
